{"id":344189,"date":"2026-11-11T18:42:39","date_gmt":"2026-11-11T13:12:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/bal-pharma-q2-results-fy27-pat-1-crore\/"},"modified":"2026-11-11T18:42:39","modified_gmt":"2026-11-11T13:12:39","slug":"bal-pharma-q2-results-fy27-pat-1-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bal-pharma-q2-results-fy27-pat-1-crore\/","title":{"rendered":"Bal Pharma Q2 Results FY27: Profit Nearly Doubles, Revenue Rs 89.95 Cr, PAT Rs 1.43 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Bal Pharma Q2 Results FY27 were declared on 11 November 2026, with consolidated revenue of Rs 89.95 Cr, up 21.52% YoY from Rs 74.02 Cr. Net profit stood at Rs 1.43 Cr against Rs 0.72 Cr a year earlier, a YoY growth of 98.61%. Operating Profit came in at Rs 8.66 Cr, up 51.13%. These quarterly results cover July to September 2026.<\/p>\n<\/div>\n

Bal Pharma Ltd<\/a> (BALPHARMA) Q2 Results FY27 announced on 11 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought Bal Pharma Q2 Results FY27 to readers with consolidated revenue of Rs 89.95 Cr and net profit (PAT) of Rs 1.43 Cr, both higher YoY. Consolidated results are the basis for every figure in this article.<\/p>\n

This Univest analysis of Bal Pharma Q2 Results moves from the headline numbers to the drivers behind them. The results analysis covers the financial highlights, business factors, outlook and risks, and begins with the table of headline figures that follows.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n